cbdMD (YCBD) Short term Debt (2016 - 2024)
cbdMD's (YCBD) quarterly Short term Debt came in at $362021.0 in Q4 2024, down 69.09% quarter-over-quarter from $1.2 million in Q3 2024.
cbdMD (YCBD) Short term Debt (2016 - 2024) Analysis & Trends
cbdMD has disclosed Short term Debt across 4 years of filings, most recently posting $362021.0 for Q4 2024.
- Short term Debt for Q4 2024 came in at $362021.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $362021.0 (changed N/A YoY), and the FY2024 annual result was $1.2 million, changed N/A from the prior year.
- Short term Debt came in at $362021.0 for Q4 2024 at cbdMD, down from $1.2 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $1.2 million in Q3 2024 to a low of $362021.0 in Q4 2024.
- The 3-year median for Short term Debt is $939826.0 (2020), against an average of $870911.6.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | cbdMD | 3,884.57 | -3.38 Mn | 3.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 362,021.00 |
| Sep 30, 2024 | 1.17 Mn |
| Mar 31, 2021 | 1.03 Mn |
| Dec 31, 2020 | 939,826.00 |
| Sep 30, 2020 | 854,000.00 |
| Sep 30, 2016 | 797,547.00 |